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III. Abstract
Embryonic stem cells are unique in their ability to grow indefinitely while maintaining
both pluripotency and self-renewal capabilities. These stem cells could be the answer to
solving many of the debilitating and devastating diseases suffered by humans. Recently,
the use of human derived embryonic stem cells has been effective in animal models in the
treatment of spinal cord injuries (Kierstead et al., 2005). Although the study of embryonic
stem cells has become increasingly popular in the last decade, there is still much research
to be done to increase the expression of valuable embryonic proteins which will induce
pluripotency in the cell. These proteins have been found to reprogram murine somatic
cells into induced pluripotent stem (iPS) cells (Takahashi and Yamanaka, 2006).
Research conducted in the last decade has revealed four transcription factors which are
vital to the induction of pluripotency in differentiated cells. iPS cells are derived using
these purified proteins through protein transfection.
This study focused on four of these transcription factors, Oct4, Sox2, Myc, and
Klf4. Although each of these factors has different functions many of them act
synergistically to promote pluripotency and self-renewal. To increase the expression of
these transcription factors by a host cell, Escherichia coli, genes for the chaperone
protein and transcription factors are induced using combinations of tetracycline and Larabinose. Chaperone plasmids increase protein folding and the ability of the host to
express foreign DNA. The purpose of this study was to combine the four transcription
factors with one of the two chaperone plasmids, pG-Tf2 and pG-KJE8 which have been
given different inducers to determine which combination for each transcription factor has
the highest expression. In order to determine this, bacterial host cell colonies were raised

4

to contain one of the four factors. Each colony was raised with one of the two chaperone
plasmids. Colonies which contained the pG-Tf2 plasmid were induced using tetracycline
only since they only contained one promoter region. Colonies containing the pG-KJE8
plasmid were induced with either tetracycline, L-arabinose or both since it contains two
promoter regions. When the pG-Tf2 chaperone plasmid was used there was positive
expression in the Sox2 colonies but no expression was seen in the soluble fraction of any
other colony. pG-KJE8 induced with only tetracycline had no expression in any colony.
Induction with L-arabinose produced a positive result in the Sox2 and Oct4 colonies.
When pG-KJE8 was induced with tetracycline and L-arabinose there was no expression
in the soluble fraction from any colony. None of the four conditions tested provided any
response in the soluble fraction from Myc or Klf4 indicating the need for further research
on the best conditions for expression of these proteins.
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IV. Introduction

Embryonic stem (ES) cells hold the future of treating many disorders such as
Parkinson’s disease, spinal cord injuries and other debilitating disorders many Americans
live with every day (Thomson et al., 1998). Derived from the inner cell mass (ICM) of
the mammalian blastocysts, ES cells are pluripotent, i.e., they can differentiate into any
one of the three germ layers. Although the use of human embryonic stem cells is much
contested, recent research has focused on the potential to use somatic cells fused with ES
cells to induce pluripotency in the somatic cell (Kazutoshi and Shinya, 2006). Stem cells
are also capable of self-maintenance and self replacement. They divide asymmetrically
and produce other stem cells which are pluripotent and undifferentiated (Katz et al.,
2002).
Takahashi and Yamanaka (2006) demonstrated that induction of pluripotent stem
cells can be achieved through the use of transcription factors in both mouse embryonic
and adult fibroblasts. Their study provides groundbreaking research into the importance
of the transcription factors used in this study. Although previous research (Katz et al.,
2002, Nichols et al., 1998, and others) has indicated the importance of certain factors, it
was not until the study by Takahashi and Yamanaka (2006) that the value of these factors
was truly tested. Takahashi and Yamanaka (2006) began with 24 potential genes that
could be used to create iPS cells from somatic cells. However, after the systematic
knockout of each factor, it was determined that there were four factors that played vital
roles and no pluripotency could be created without them.
The transcription factors of interest in this study, and the ones determined to be
important by Takahashi and Yamanaka (2006), are Oct 4, Sox2, MYC and Klf4. Oct 4
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(also known as Oct3, Rosner et al., 1990) is a POU domain-containing transcription
factor which is encoded by Pou5f (Loh et al., 2006). POU factors promote cell
proliferation both directly and indirectly (Nichols et al. 1998). Several studies (Loh et al.,
2006; Nichols et al., 1998) have identified this transcription factor as an essential factor
in the maintenance of pluripotency in the early embryo and germ cells. Oct4 is a key
regulator in the formation of the inner cell mass during preimplantation development
(Loh et al., 2006). The ICM develops into the pluripotent cells of nontrophoblast
extraembryonic tissues. The ICM has high stem cell populations which can be adapted to
a variety of conditions. These stem cells will remain pluripotent through late gastrulation
(Nichols et al., 1998). Oct4 is required for the first cell fate (Avilion et al., 2003). Oct4 is
distinguished by its exclusive expression in the blastomere and its pluripotent early
embryonic cells (Rosner et al., 1990). Oct4-/- embryos will develop to a blastocyst stage
but the ICM cells are not pluripotent. These cells are placed into the extraembryonic
trophoblast lineage of which descendents are restricted to this generation (Nichols et al.
1998). Oct4 can regulate the expression of multiple genes through its interaction with
another transcription factor that is also present in pluripotent cells (Nichols et al., 1998).
Sox2 (SRY- related HMG box), is a member of the gene family that includes testisdetermining factor (Yuan et al., 1995; Maruyama et al., 2005). In the developing embryo,
Sox2 RNA can first be detected in the morula stage and is specifically seen in the ICM of
the blastocyst. Sox2 identifies the pluripotent lineage in the mouse embryo and is
associated with the uncommitted stem and precursor cells of the central nervous system
(Avilion et al., 2003). Sox2 and its association with Oct4 are absolutely essential for the
establishment of pluripotency in embryonic cells (Maruyama et al., 2005; Yuan et al.,
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1995). Sox proteins are highly conserved high mobility group (HMG) domains that are
involved in DNA recognition and binding. Sox2 plays an essential role in cell
differentiation, development and organogenesis (Maruyama et al., 2005). In the absence
of Sox2 cells change their identity and do not remain in the undifferentiated state
(Avilion et al., 2003) Sox2 can form a ternary complex with Oct4 and can promote
transcriptional activation (Yuan et al., 1995). Sox2 binds to AACAA(A/T)G while Oct4
binds to ATT(A/T)GCAT. Embryos that are Sox2- and Oct4- null are lethal in the periimplantation stages indicating that Sox2 and Oct4 are essential to maintain pluripotency
in embryonic stem cells (Maruyama et al., 2005) In the early embryo, the expression of
these two transcription factors overlap in the morula, ICM, epiblast and germ cells
suggesting they have a parallel role in pluripotency (Avilion et al., 2003).
The third transcription factor, Myc, has been implicated in the development of
many human tumors. Elevated Myc expression has bee known to contribute to
tumorigenesis and has long been implicated in unrestricted cell proliferation and the
inhibition of cell differentiation (Adhikary and Eilers, 2005). Other studies (Domashenko
et al., 1997) have indicated that the Myc gene family is essential for preimplantation
development. It has been estimated that Myc may be bound to approximately 25,000 sites
in the human genome where it regulates a significant portion of all genes in an organism
(Adhikry and Eilers, 2005). Gene knockout experiments revealed that these genes are
absolutely essential for embryogenesis however; a lack of one member of the Myc family
does not effect preimplantation development leading to the thought that members of the
family may have overlapping roles (Domashenko et al., 1997). The Myc genes can both
activate transcription and repress it depending on its binding location. Myc that binds to
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the DNA recognition sequence (CACA/GTG) will activate transcription while binding to
the promoter, Miz1, will repress transcription (Adhikry and Eilers, 2005).
Klf4, Krüppel-like factor 4, is a transcription factor which is expressed in the
epithelia of the skin, lungs, gastrointestinal tract as well as several other organs. Klf4 is
reported to play a vital role in both cell proliferation and differentiation (Katz et al.,
2002). Klf4 can activate and repress genes that are involved in cell cycle regulation and
differentiation and levels of this transcription factor rise following DNA damage
(Rowland et al., 2005). Mice that lack the Klf4 gene die within 15 hours of birth and have
mutations in late-stage differentiation (Katz et al., 2002). Klf4 can switch from a growthinhibiting tumor suppressor to a growth-promoting oncogene depending on the presence
or absence of unidentified factors (Rowland et al., 2005).
Previously, many studies have used a virus or plasmid to express the transcription
factors; however, both methods carry a risk of genomic integration and thus disruption of
gene expression. The study completed by Takahashi and Yamanaka (2006) retrovirally
introduced the genes that encoded the transcription factors. This study will use proteins to
induce expression which theoretically carry no risk of alteration in the genomic sequence
of the iPS cell. Zhou et al. (2009) also used recombinant cell-penetrating reprogramming
proteins and had great success in the creation of iPS cells from murine embryonic
fibroblasts.
In order to increase the ability of Escherichia coli to express the foreign
transcription factors chaperone coexpression plasmids are added to the bacteria. DnaKDnaJ-GrpE and GroEL-GroES are the most common chaperone proteins used to assist
the host cell in protein folding and decrease the incidence of inclusion bodies (Nishihara

9

et al., 1998). Without the addition of chaperone proteins, proteins in E.coli are often
rapidly degraded or have an inability to form their native tertiary structures (Nishihara et
al., 1998). Molecular chaperones suppress aggregation reactions and increase proper
folding through ATP-coordinated cycles (Thomas et al., 1997).
The purpose of this study was to find the best combination of transcription factor
with chaperone protein inducer. Chaperone plasmids such as pG-KJE8, which was used
in this study, can be induced to express different chaperone proteins depending on the
type of inducer used in the media. In some chaperone plasmids, there are two promoter
regions which are activated with different inducers. By inducing a different promoter, a
different chaperone within the plasmid can be activated. Of the two chaperone plasmids
used in this study, only pG-KJE8 contains two promoters which will be induced
separately and then jointly to test its effectiveness. pG-Tf2 will only be tested with one
since it contains a single promoter region. This study will look at four conditions;
1. Chaperone plasmid pG-Tf2 induced with tetracycline
2. Chaperone plasmid pG-KJE8 induced with tetracycline
3. Chaperone plasmid pG-KJE8 induced with L-arabinose
4. Chaperone plasmid pG-KJE8 induced with L-arabinose and
tetracycline
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V. Materials and Methods
Bacterial strain
E.coli BL21 strain DE3 [hsdSB(rB-mB) gal dcm (DE3)] was purchased from
Novagen® (Darmstadt, Germany). BL21DE3 is commonly chosen as a host for protein
expression since it is deficient in both the lon, and ompT proteases. The lon protease is
ATP-dependent and stabilizes some foreign proteins while a lack of ompT indicates a
lack of outer membrane proteases which can improve the recovery of the recombinant
proteins. The DE3 indicates that this host strain contains a lambda prophage. In this strain
the gene for T7 RNA polymerase is under the control of the lacUV5 promoter.
Chaperone Plasmids
Table 1.
Chaperone Plasmids
Promoter Inducer

Plasmid

Chaperone

pG-KJE8

dnaK-dnaJ-grpE
groES-groEL
groES-groEL-tig

pG-Tf2

araB
Pzt1
Pzt1

Resistant
Marker
L-Arabinose Cm
Tetracycline
Tetracycline Cm

All cell cultures were initially inoculated in a LB medium containing 20 µg/ml
chloramphenicol and 50 µg/ml ampicillin for plasmid selection. In condition one, the
chaperone plasmid pG-KJE8 was used along with 0.5 mg/ml of L-arabinose to induce the
araB promoter. For the second condition, 5 ng/ml of Tetracycline was added to induce
the Pzt1 promoter. Both promoters are present in pG-KJE8 and are tested separately to
determine any differences. Condition three will test the combined effects of L-arabinose
and Tetracycline on protein expression. When pG-Tf2 was used instead of pG-KJE8, as
in condition four, only Tetracycline was added to the plate to induce the Pzt1 promoter
region for the groES-groEL-tig chaperone for protein expression
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Figure 1. Structure of chaperone coexpression plasmids pG-KJE8 (a) and pG-Tf2 (b).

a.

b.

ori, replication origin of pACYC, tetR, tetR repressor gene, Cmr, chloramphenicol
resistance, araC, araC repressor gene, araB, promoter-operator

Bacterial Transformation
Transformation was completed following the protocol provided by Novagen®
(Darmstadt, Germany). Cells were thawed and mixed gently to ensure they were evenly
suspended and 20 µl aliquots of cells were placed in pre-chilled tubes. 1 µl of DNA
solution was added. Tubes were heated for 30 seconds in 42oC water bath and then placed
on ice for two minutes. Prior to this, 0.5 µl of one chaperone plasmid was fused with 0.5
µl one of the four transcription factors studied, Oct-4, Sox-2, MYC, and KLF4 and
referred to as ON (Oct-4, N terminal), SN (Sox-2, N terminal), MN (MYC, N terminal),
and KN (KLF 4, N terminal).

Bacterial Induction and Extraction
Bacterial induction was completed following a slow induction protocol prepared
by Arur and Nayak (See attached protocol). Colonies were selected and grown overnight
at 30oC in LB + AMP + Chloramphenicol in a 15 ml snap cap on a shaker. The solution

12

was diluted to 1:50 in 2 ml of LB+AMP+Chloramphenicol and grown for 3-4 hours at 37
o

C. One ml of LB + AMP + Chloramphenicol +1 mM IPTG was prepared and

prewarmed to 37 oC prior to use. After 3-4 hours, 1 ml was removed from tubes and spun
at maximum x g for 30 sec at room temperature. The supernatant was removed and the
pellet frozen at -20 oC. A slow induction of protein expression was chosen to enhance
solubility. 1 ml of LB + AMP + Chloramphenicol+ 1 mM IPTG at 19 oC was added and
incubated at 19 oC for 12 hours. The final concentration of IPTG was 0.5 mM. One ml
from the induced sample was transferred and spun at max for 30 seconds at room
temperature and the supernatant was removed. Cells were frozen at -20 oC until needed
later.
To extract the proteins 1 ml of the bacteria was spun at 1200 x g for 30 seconds at
room temperature. An extractor buffer, xTractor buffer from clontech laboratories, was
created from 2 ml of xTractor buffer, 2.5 µl of DNAse, 20 µl of lysosome (1 mg/ml) and
2 µl of PMSF. The pellet is resuspended and rocked at room temperature for 15 minutes
and then spun at 12000 x g for 20 minutes at 4oC. The supernatant is then saved at put on
ice while the pellet is resuspended with 200 µl of 2% SDS and heated to 95oC for 10
minutes. In additional tubes, 10 µl of 5x reducing buffer and 40 µl of the pellet or
supernatant were added. All tubes were heated at 95oC for 10 minutes and then spun for a
short spin.

Protein Expression Analysis and Quantification
Gels for electrophoresis were created using the standard protocol for 10%
resolving gel (4.9ml DDI H20, 2.5 ml 30% degassed Acrylamide/Bis, 2.5 ml gel buffer,
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0.1ml 10% SDS, 100µl APS and 10µl of TEMED. 1.5 M Tris-HCl (pH 8.8) was used as
the gel buffer. A 4% stacking gel was used (6.4ml DDI H2O, 1ml 30% Degassed
Acrylamide/Bis, 2.5ml gel buffer, 0.1ml 10% SDS, 100µl APS dilution and 10µl of
TEMED). Proteins were loaded at 15µl per sample and 10µl of marker. Samples were run
for 37 minutes at 200 v and were transferred to a membrane soaked in Methanol. These
were run in TGS buffer at room temperature over night at 120 mA.
Protein expression was analyzed using the Universal His Western Blot Kit 2.0
Protocol from Clontech Laboratories. Instead of using PBST1 buffer as recommended,
TBST (10 mM Tris (pH 7.5), 100 mM NaCl and 0.1% Tween 20) buffer was used for the
first wash for 30 minutes. TBST was used rather than the recommended buffer based on
previous experience from Yong Tang, and its ability to produce the same quality signal
and a clean background for quantification. The primary buffer, His-Detection Reagent,
was diluted with 1µl of reagent and 99 µl of 0.9% NaCl. The secondary antibody,
Streptavidin-HRP, was diluted with 1 µl of Streptavidin-HRP in 99 µl of PBST3.
Following the end of the protocol the blots were placed protein side up in a
chemiluminescence film cassette and put through a film development process to expose
the proteins to the chemiluminescence film. These films were placed on a docucam and
the QuantityOne software from Biorad was used to reduce the backgrounds and quantify
the volume of the bands. This volume was adjusted for the volume of the background and
the adjusted volumes were used to compare the intensity of protein expression.
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VI: Results:

pG-Tf2
Western blot analysis of the four transcription factors SN, ON, KN, MN revealed that
while tetracycline is the preferred inducer for the Pzt1 promoter region on pG-Tf2, there
were few positive results when used with these factors. Of the four transcription factors,
tetracycline induction of the pG-Tf2 chaperone plasmid produced the best result in the
SN colonies as seen in Table 2 and 3.

Table 2. pG-Tf2
SN 1 Colony
Gel 1

PELLET
SOLUBLE

No Chaperone

Tet Pellet
pG-Tf2

pG-Tf2
Blank

pG-Tf2
No Chaperone

pG-Tf2
Tet induced

---

++
--

++
+

Tet Soluble
pG-Tf2

Tet Pellet
pG-KJE8

pG-KJE8
Tet induced

++
-(above) Expression
strength of bands using
adjusted volume from
Western Blot test in the
SN1 Colony of E. coli
bacteria. See below for
key (left) Figure 2.
Western Blot printout of
the SN1 colony using
QuantityOne computer
program to quantify the
strength of expression
compared to
background volume.
% Adjusted Volume:
00.0-20.5: +
20.5-40.5: + +
40.5-60.5: + + +
60.5-80.5: + + + +
80.5-100: + + + + +
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SN1 was a fresh colony while SN3 had been grown earlier and frozen until a later time.
SN1 had a higher expression ratio (Pellet: 34.66 / Soluble: 1.75 ratio: 19.8) than the SN3
colony which showed closer volumes in both the pellet and soluble fraction (Pellet: 24.3/
Soluble: 14.2 ratio: 1.71)
Table 3. pG-Tf2 SN3 colony
SN 3 COLONY
Gel 1

PELLET
SOLUBLE

pG-Tf2
Blank

pG-Tf2
No Chaperone

pG-Tf2
Tet induced

pG-KJE8
Tet induced

---

+
+

++
+

++
--

No Chap
Pellet

Tet Pellet
pG-KJE8

Tet Soluble
pG-Tf2

Tet
Pellet
pG-Tf2

No Chap
Soluble

(above)
Expression
strength of bands
using adjusted
volume from
Western Blot test
in the SN3 Colony
of E. coli bacteria
(left) Figure 3.
Western Blot
printout of the
SN3 colony using
QuantityOnecomp
uter program to
quantify the
strength of
expression compared
to background volume.

There was no expression seen in the soluble fraction when utilizing pG-Tf2 and
tetracycline in combination with the other transcription factors. There was positive
expression of ON1 and ON2 in the pellet but no expression was seen in the soluble
fraction in either of these colonies.
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pG-KJE8
When using the pG-KJE8 in conjunction with tetracycline there was no expression in the
soluble fraction of any transcription factor although variable expression could be seen in
both the SN1 and SN3 pellet. When tetracycline was used to induce expression in the
remaining samples, SN1, ON, KN, and MN, there was no expression in the pellet or
soluble fraction. Although there was no expression in these there was expression in the
positive control which was run at the same time (see figure 4). There was no expression
in the SN1 colony in this gel, however, in a previous experiment there was positive pellet
expression in the SN1 and SN3 colonies although this expression was highly variable
with 23.92 and 49.57 respectively (see table 2 and table 3).
Figure 4. Comparison of the lack of expression in the tetracycline induced pG-KJE8
plasmid colonies and the positive expression in the control colony.

Test Colonies

Control Colony

When induced with L-arabinose both SN1, SN3 and ON colonies showed positive results
in the pellet and soluble fraction although there was more overall expression in SN1 than
the ON colonies as seen in table 4 and figure 5 below. SN1 had a percent adjusted
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volume in the pelleted fraction of 59.9 with the soluble fraction at 7.61 % for a ratio of
7.87 (a comparison of ratios can be seen in table 6). SN3 had a pelleted volume of 31.61
and a soluble fraction of 12.92 % with a ratio of 2.44. ON1 had a ratio of 1.18 with
17.94% adjusted volume in the pellet and 15.20% adjusted volume in the soluble fraction.

Table 4. pG-KJE8 induction with L-arabinose

SN1
+++
+

PELLET
SOLUBLE

SN1
P

SN1
S

ON1
P

ON1
S

ON1
+
+

KN1
---

MN1
--above) Expression
strength of bands
using adjusted
volume from
Western Blot test in
the pG-KJE8
colonies induced
with L-arabinose
(left) Figure 5.
Western Blot
printout of the Larabinose induced
colony using
QuantityOne
computer program
to quantify the
strength of
expression
compared to
background volume.

The final condition tested was the combination of induction with both tetracycline and Larabinose to induce both the dnaK-dnaJ-grpE and groES-groEL chaperones. When both
were used there was positive expression in the pellet for SN1, SN3, ON and KN, however
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there was no positive expression for MN in either the pellet or soluble fraction. Pellet
expression was relatively constant between the different transcription factors.
Table 5. pG-KJE8 induced with tetracycline and L-arabinose
ON1
+++
--

PELLET
SOLUBLE

SN
++
--

KN
++
--

MN
---

Ratios:
Table 6. Ratios of pellet to soluble fraction expression using percent adjusted volume

PELLET
SOLUBLE
RATIO

SN1 pG-Tf2
Tet Induced

SN3 pG-Tf2
Tet Induced

SN1pG-KJE8
L-Arabinose

ON1pG-KJE8
L-Arabinose

34.66
1.75
19.81

24.3
14.2
1.71

59.9
7.61
7.81

17.94
15.20
1.18

VII: Discussion:
Embryonic stem cell research is still developing. Any increase in expression of
the transcription factors which are known to play a key role in the maintenance of
pluripotency in developing embryonic cells is a step towards further cloning and eventual
medical applications of this research. There are many ethical arguments over the use of
human embryos in research, but, by the ability to induce bacterial cells to express the
proteins responsible for pluripotent and undifferentiated cells a patients own cells may
eventually be used in their own treatment. Recently, four separate research groups have
generated iPS cells from patients with a variety of neurodegenartive diseases including
amyotrophic lateral sclerosis (Dimos et al., 2008) and Parkinson’s Disease (Soldner et al.,
2009). Researchers have also derived iPS cells from monkeys and rats and many are
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looking to this as the future for drug discovery and the pharmacological industry
(Yamanaka, 2009)
There are many factors which can play a role in the overall expression which have
yet to be tested. There are different ways to raise the bacterial colonies and this could
effect how well they are able to produce the protein. This study used the minimum
suggested amount of inducer which may play a vital role in the induction of the
expression. Other research might include different chaperone plasmids that could
increase the ability of the host to express the protein. Overall, the increased expression in
any one of the transcription factors has great implications for further research and
medical potential.
Yamanaka (2009) highlighted many potential uses for the current research being
conducted on iPS cells including their use in regenerative medicine. Although much
research still needs to be completed before these discoveries can have human
applications, Yamanaka (2009) points to their usefulness in eliminating patient rejection
of a donor and the reduction of the ethical issues surrounding the use of a human embryo.
In January 2009, the US Food and Drug Administration approved the first clinical trials
to use human ES cells to treat human spinal cord injuries. With continued research there
may be many more potential applications for this research.
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Appendix 1
IPTG Induction and Extraction of Proteins from Bacteria
Prepared by Swathi Arur and Sudhir Nayak
Induction in bacteria can be performed using one of two basic methods. Fast
induction does not work for all proteins and can give you suboptimal yields. Slow
induction can enhance the solubility of some proteins. The method that's best for you
will depend on your particular protein and the application. If you want optimal solubility
both should be tested before scaling up. This protocol is generalized and will vary based
on a variety of factors such as the bacterial strain, recombinant protein, and parent
plasmid.
Fast induction
1) From a relatively fresh plate (<4 weeks) pick a colony and grow O/N at 30deg
C (or 37deg C) in 1-2ml LB+AMP(or other selection) in a 15ml snap cap tube on a
rotator or shaker.
2) Dilute 1:50 (1:100 if 37deg O/N) in 2ml LB+AMP and grow 3-4 hours at
37deg C in 15ml snap cap tube in a rotator.
4) Prepare 1ml LB+AMP+1mM IPTG in a 15ml conical and prewarm to 37dec C
about 10min before use.
5) After 3-4hrs remove 1ml from tubes at 37deg C and place in labeled 1.5ml
tubes. Spin at max, 30sec, RT, and remove supe. Freeze pellet at -20 until needed.
THIS IS THE UNINDUCED CONTROL.
6) Add prewarmed 1ml LB+AMP+1mM IPTG to 15ml snap cap tube and return
to 37 deg C for 3-4 hours. This will get the final volume back to 2ml and the final
concentration of IPTG to 0.5mM.
7) After 3-4hrs transfer 1ml from induced sample to labeled 1.5ml tubes and spin
at max, 30sec, RT, and remove supe. Freeze pellet at -20 until needed. THIS IS THE
INDUCED SAMPLE.
8) Sample preparation for SDS-PAGE: Add 100ul of 1X loading buffer (see
solutions below) with 1% BME to uninduced and induced samples. Vortex for 10sec to
1min or until there are no clumps of bacteria. Boil 3-5min, spin at max, 30sec, RT, and
load 5-25ul (usually 10ul) depending on gel (amount of protein, size of pellet, Western,
etc.).
Slow induction
For slow induction of protein follow fast induction protocol with the following
changes:
6) Add 20deg 1ml LB+AMP+1mM IPTG to 15ml snap cap tube and incubate rotating or
shaking at 20deg C for 12-16 hours. This will get the final volume back to 2ml and the
final concentration of IPTG to 0.5mM.
7) After 12-16hrs transfer 1ml from induced sample to labeled 1.5ml tubes and spin at
max, 30sec, RT, and remove supe. Freeze pellet at -20 until needed. THIS IS THE
INDUCED SAMPLE.
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